Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: The influence of smoking

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 4, 1997, Pages 225-231

  Okkels, Henrik ^a   Sigsgaard, Torben ^a   Wolf, Hans ^b   Autrup, Herman ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; GLUTATHIONE TRANSFERASE;

ACETYLATOR PHENOTYPE; ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DENMARK; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 0030940149     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lower, G. M., Jr., Nilsson, T., Nelson, C. E., Wolf, H., Gamsky, T. E., and Bryan, G. T. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ. Health Perspect., 29: 71-79, 1979.
2. Wolf, H., Lower, G. M., Jr., and Bryan, G. T. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines. Scand. J. Urol. Nephrol., 14: 161-165, 1980.
3. Cartwright, R. A., Glashan, R. W., Rogers, H. J., Ahmad, R. A., Barham-Hall, D., Higgins, E., and Kahn, M. A. Role of N-acetyl transferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet, 2: 842-846, 1982.
4. Evans, D. A. P., Eze, L. C, and Whibley, E. J. The association of the slow acetylator phenotype with bladder cancer. J. Med. Genet., 20: 330-333, 1983.
5. Mommsen, S., and Aagaard, J. Susceptibility in urinary bladder cancer. Acetyltransferase phenotypes and related risk factors. Cancer Lett., 32: 199-205, 1986.
6. Vineis, P. Epidemiology of cancer from exposure to arylamines. Environ. Health Perspect., 102(Suppl. 6): 7-10, 1994.
7. Kadlubar, F. F., Butler, M. A., Kaderlik, K. R., Chou, H-C., and Lang, N. P. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Health Perspect., 98: 69-74, 1992.
8. Hein, D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948: 37-66, 1988.
9. Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P., and Kadlubar, F. F. Role of aromatic amine acelyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in human urinary bladder. Cancer Res., 55: 5230-5237, 1995.
10. Patrianakos, C., and Hoffmann, D. Chemical studies of tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke. J. Anal. Chem., 3: 150-154, 1979.
11. Bartsch, H., Malaveille, C., Friesen, M., Kadlubar, F. F., and Vineis, P. Black (air cured) and blond (flue cured) tobacco - cancer risk. IV. Molecular dosimetry studies implicate aromatic amines as bladder carcinogens in humans. Eur. J. Cancer, 29A: 1199-1207, 1993.
12. Vineis, P., Bartsch, H., Caporaso, N., Harrington, A. M., Kadlubar, F. F., Landi, M. T., Malaveille, C., Shields, P. G., Skipper, P., Talaska, G., and Tannenbaum, S. R. Genetically N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.), 369: 154-156, 1994.
13. Talaska, G., Al-Juburi, A. Z. S. S., and Kadlubar, F. F. Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxy-guanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA, 88: 5330-5354, 1991.
14. Deguchi, T., Mashimo, M., and Suzuki, T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acelyltransferase in human liver. J. Biol. Chem., 265: 12757-12760, 1990.
15. Blum, M., Grant, D. M., McBride, W., Heim, M., and Meyer, U. A. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol., 9: 193-203, 1990.
16. Kloth, M. T., Gee, R. L., Messing, E. M., and Swaminathan, S. Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells. Carcinogenesis (Lond.), 15: 2781-2787, 1994.
17. Frederickson, S. M., Messing, E. M., Reznikoff, C. A., and Swaminathan, S. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol., Biomarkers & Prev., 3: 25-32, 1994.
18. Weber, W. W., and Vastis, K. P. Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral blood. Pharmacogenetics, 3: 209-212, 1993.
19. Vastis, K. P., and Weber, W. W. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys., 301: 71-76, 1993.
20. Bell, D. A., Badawi, A. F., Lang, N. P., Ilett, K. F., Kadlubar, F. F., and Hirvonen, A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation in bladder and colon tissue. Cancer Res., 55: 5226-5229, 1995.
21. Evans, D. A. P. N-acetyltransferase. In: W. Kalow (ed.), Pharmacogenetics of Drug Metabolism, pp. 95-178. New York: Pergamon Press, 1992.
22. Blum, M., Demierre, A., Grant, D. M., Heim, M., and Meyer, U. A. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. USA, 88: 5237-5241, 1991.
23. Hickman, D., and Sim, E. N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem. Pharmacol, 42: 1007-1014, 1991.
24. Vastis, K. P., Martell, K. J., and Weber, W. W. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. USA, 88: 6333-6337, 1991.
25. Ohsako, S., and Deguchi, T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J. Biol. Chem., 265: 4630-4634, 1990.
26. Hein, D. W., Ferguson, R. J., Doll, M. A., Rustan, T. D., and Gray, K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum. Mol. Genet., 3: 729-734, 1994.